0001104659-21-054978.txt : 20210426
0001104659-21-054978.hdr.sgml : 20210426
20210426170911
ACCESSION NUMBER: 0001104659-21-054978
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210422
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xu Yuan
CENTRAL INDEX KEY: 0001858214
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 21854882
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm2114204-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-04-22
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001858214
Xu Yuan
C/O AKERO THERAPEUTICS, INC.,
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
28.79
2021-04-22
4
A
0
26000
0
D
2031-04-22
Common Stock
26000
26000
D
This option shall vest and become exercisable in 36 equal monthly installments, commencing on April 22, 2021.
/s/ Jonathan Young, attorney-in-fact
2021-04-26